Efficacy of tolvaptan in transurethral resection of prostate

Efficacy of tolvaptan in transurethral resection of prostate: A prospective randomized study - Efficacy of tolvaptan in transurethral resection of prostate

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220168

Enrollment

Registered

2014-03-07

Start date

2014-05-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hypertrophy

Interventions

Intervention type:DRUG Name of intervention:Efficacy of tolvaptan in transurethral resection of prostate: A prospective randomized study Dose form / Japanese Medical Device Nomenclature:TABLET Route o

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Benign prostatic hypertrophy 2) male: 20-89 year-old 3) patients showed consent of this study

Exclusion criteria

Exclusion criteria: 1)emergency operation 2)simultaneously having different operation 3)serum sodium level =35 14)Coagulation disorder 15)Severe complication with a diagnosis of 6 month remaining 16)Participation in other intervention studies 17)being judged as not appropriate for this study

Design outcomes

Primary

Measure	Time frame
Change of serum sodoum and occurrence of TUR syndrome	—

Secondary

Measure	Time frame
1) perioperative mortality 2) neurological and circulatory abnormality 3) serum creatinine levels 4) lactate levels	—

Countries

Japan

Contacts

Public ContactJunko Nakahira

Osaka Medical College

ane052@osaka-med.ac.jp+81-72-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026